Photo of Astrid Murumägi
  • PL 20 (Tukholmankatu 8)

    00014

    Finland

20032019

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

Astrid Murumägi is a senior scientist at the Kallioniemi group. She received her PhD in Molecular Immunology at the University of Tampere.  During her postdoctoral training she transitioned to systems biology and genomics by joining Prof. Olli Kallioniemi´s team at FIMM in 2009. Her work is focused on applying systems medicine in cancer research. She is involved in the FIMM Grand Challenge on Individualized Systems Medicine program. More specifically, she is responsible for ovarian cancer and melanoma functional precision medicine projects, where patient-derived cancer cells are used for comprehensive drug sensitivity testing and molecular profiling to identify best treatment strategies for patients. In addition she is involved in several collaboration projects where the drug testing platform has been applied to uncover novel drug vulnerabilities in cancer cells.

Fields of Science

  • 3111 Biomedicine
  • 318 Medical biotechnology
  • 3122 Cancers

International and National Collaboration Publications and projects within past five years.

Publications

Anagrelide for Gastrointestinal Stromal Tumor

Pulkka, O-P., Gebreyohannes, Y. K., Wozniak, A., Mpindi, J-P., Tynninen, O., Icay, K., Cervera, A., Keskitalo, S., Murumägi, A., Kulesskiy, E., Laaksonen, M., Wennerberg, K., Varjosalo, M., Laakkonen, P., Lehtonen, R., Hautaniemi, S., Kallioniemi, O., Schöffski, P., Sihto, H. & Joensuu, H., 1 Mar 2019, In : Clinical Cancer Research. 25, 5, p. 1676-1687 12 p.

Research output: Contribution to journalArticleScientificpeer-review

Clinical implementation of precision systems oncology in the treatment of ovarian cancer based on ex-vivo drug testing and molecular profiling

Murumagi, A., Ungureanu, D., Khan, S., Hirasawa, A., Arjama, M., Valimaki, K., Mikkonen, P., Niininen, W., Kumar, A., Eldfors, S., Pellinen, T., Pietiainen, V., Magi, A., Koivisto-Korander, R., Tapper, J., Loukovaara, M., Aittokallio, T., Butzow, R. & Kallioniemi, O., Jul 2019, In : Cancer Research. 79, 13, 2 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting

Karvonen, H., Perttila, R., Niininen, W., Hautanen, V., Barker, H., Murumagi, A., Heckman, C. A. & Ungureanu, D., 25 Apr 2019, In : Oncogene. 38, 17, p. 3288-3300 13 p.

Research output: Contribution to journalArticleScientificpeer-review

Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies

Sveen, A., Bruun, J., Eide, P. W., Eilertsen, I. A., Ramirez, L., Murumägi, A., Arjama, M., Danielsen, S. A., Kryeziu, K., Elez, E., Tabernero, J., Guinney, J., Palmer, H. G., Nesbakken, A., Kallioniemi, O., Dienstmann, R. & Lothe, R. A., 15 Feb 2018, In : Clinical Cancer Research. 24, 4, p. 794-806 13 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Drug-Sensitivity Screening and Genomic Characterization of 45 HPV-Negative Head and Neck Carcinoma Cell Lines for Novel Biomarkers of Drug Efficacy

Lepikhova, T., Karhemo, P-R., Louhimo, R., Yadav, B., Murumägi, A., Kulesskiy, E., Kivento, M., Sihto, H., Grenman, R., Syrjänen, S. M., Kallioniemi, O., Aittokallio, T., Wennerberg, K., Joensuu, H. & Monni, O., Sep 2018, In : Molecular Cancer Therapeutics. 17, 9, p. 2060-2071 12 p.

Research output: Contribution to journalArticleScientificpeer-review

Activities

  • 12 Organisation and participation in conferences, workshops, courses, seminars
  • 2 Other
  • 1 Public Talks
  • 1 Invited talk

AACR Annual Meeting

Astrid Murumägi (Participant)
29 Mar 20193 Apr 2019

Activity: Other activity typesOther

Functional Drug Screening meeting

Astrid Murumägi (Attendee)
12 Mar 201913 Mar 2019

Activity: Participating in or organising an event typesOrganisation and participation in conferences, workshops, courses, seminars

Precision medicine in oncology

Astrid Murumägi (Speaker)
13 Sep 2019

Activity: Talk or presentation typesInvited talk

Functional Precision Medicine Summit

Astrid Murumägi (Attendee)
30 Mar 2019

Activity: Participating in or organising an event typesOrganisation and participation in conferences, workshops, courses, seminars

National workshop on Personalized/Precision Cancer Medicine (PCM)

Astrid Murumägi (Attendee)
6 Apr 2016

Activity: Participating in or organising an event typesOrganisation and participation in conferences, workshops, courses, seminars